Myriad Genetics, Inc. MYGN recently announced a collaboration with OptraHEALTH with the aim of implementing a cognitive ChatBOT, Gene. The AI-powered ChatBOT will provide genetic and financial assistance information to prospective patients of hereditary cancer. Notably, the Gene knowledge platform, which is a Health Insurance Portability and Accountability Act compliant, […]